NCT01016483 - Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer | Biotech Hunter

Enrollment

141

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

April 30, 2015

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG

Pimasertib

DRUG

Gemcitabine

DRUG

Placebo

Trial Locations (2)

For Recruiting Locations in the United States, please Contact U.S. Medical Information, Rockland

For Recruiting Locations outside the United States, Please contact the Merck KGaA Communication Center, Darmstadt